Alba M et al. CJC-1295 GHRH analog normalizes growth in the GHRH knockout mouse
pubmed.ncbi.nlm.nih.gov/16822960 ↗
Cited by:
CJC-1295 No DACCJC-1295 No DAC + Ipamorelin Blend
Anisimov VN et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice
pubmed.ncbi.nlm.nih.gov/14501183 ↗
Cited by:
Epitalon
Anisimov VN et al. Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray
pubmed.ncbi.nlm.nih.gov/15159690 ↗
Cited by:
Cortagen
Anisimov VN et al. Studies of the effects of Vilon and Epithalon on gene expression in mouse heart using DNA-microarray technology
pubmed.ncbi.nlm.nih.gov/12360356 ↗
Cited by:
Vilon
Avolio F et al. Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line
pubmed.ncbi.nlm.nih.gov/35408963 ↗
Cited by:
Chonluten
Baar MP et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging
pubmed.ncbi.nlm.nih.gov/28340339 ↗
Cited by:
FOXO4-DRI
Barnhart KF et al. A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys
pubmed.ncbi.nlm.nih.gov/22072637 ↗
Cited by:
Adipotide
Berlanga-Acosta J et al. Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure
pubmed.ncbi.nlm.nih.gov/16417467 ↗
Cited by:
GHRP-6
Blüher M et al. Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
pubmed.ncbi.nlm.nih.gov/38330987 ↗
Cited by:
Survodutide
Bornstein NM et al. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders
pubmed.ncbi.nlm.nih.gov/22514792 ↗
Cited by:
Cerebrolysin
Brines M et al. ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes
pubmed.ncbi.nlm.nih.gov/25387363 ↗
Cited by:
Ara-290
Chang CH et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
pubmed.ncbi.nlm.nih.gov/21030672 ↗
Cited by:
BPC-157
Coviello AD et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression
pubmed.ncbi.nlm.nih.gov/15713727 ↗
Cited by:
HCG
Dahan A et al. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density
pubmed.ncbi.nlm.nih.gov/24136731 ↗
Cited by:
Ara-290
Davitt K et al. The anti-cancer peptide PNC-27 induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line
pubmed.ncbi.nlm.nih.gov/25117093 ↗
Cited by:
PNC-27
Djillani A et al. Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity
pubmed.ncbi.nlm.nih.gov/28955242 ↗
Cited by:
PE-22-28
Dolotov OV et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus
pubmed.ncbi.nlm.nih.gov/16996037 ↗
Cited by:
Adamax
Doroudian G et al. Sustained delivery of MGF peptide from microrods attracts stem cells and reduces apoptosis of myocytes
pubmed.ncbi.nlm.nih.gov/24908137 ↗
Cited by:
PEG MGF
Dorr RT et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
pubmed.ncbi.nlm.nih.gov/8637402 ↗
Cited by:
Melanotan II
Enebo LB et al. Safety, tolerability, pharmacokinetics of concomitant administration of cagrilintide with semaglutide 2.4 mg for weight management
pubmed.ncbi.nlm.nih.gov/33894838 ↗
Cited by:
CagrilintideCagrilintide + Semaglutide (CagriSema) Blend
Finkel DM et al. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin
pubmed.ncbi.nlm.nih.gov/3928676 ↗
Cited by:
HMG
Frieboes RM et al. Effects of growth hormone-releasing peptide-6 on the nocturnal secretion of GH, ACTH and cortisol and on the sleep EEG in man
pubmed.ncbi.nlm.nih.gov/10336729 ↗
Cited by:
GHRP-6
Hadley ME et al. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization
pubmed.ncbi.nlm.nih.gov/16412534 ↗
Cited by:
PT-141 (10mg) + Melanotan II (10mg) Stack
Heffernan MA et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice
pubmed.ncbi.nlm.nih.gov/11713213 ↗
Cited by:
AOD-9604AOD-9604 + CJC-1295 + Ipamorelin Blend
Hsieh TC et al. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy
pubmed.ncbi.nlm.nih.gov/23260550 ↗
Cited by:
HCG
Hussain MA et al. The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction
pubmed.ncbi.nlm.nih.gov/35837314 ↗
Cited by:
Kisspeptin
Kannengiesser K et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease
pubmed.ncbi.nlm.nih.gov/18092346 ↗
Cited by:
KPVTri-Heal (TB-500 + BPC-157 + KPV)
Kannt A et al. A small molecule inhibitor of nicotinamide N-methyltransferase for the treatment of metabolic disorders
pubmed.ncbi.nlm.nih.gov/29483571 ↗
Cited by:
5-Amino-1MQ
Khavinson VK et al. Neuroprotective Effects of Tripeptides -Epigenetic Regulators in Mouse Model of Alzheimers Disease
pubmed.ncbi.nlm.nih.gov/34071923 ↗
Cited by:
Pinealon
Khavinson VK et al. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes
pubmed.ncbi.nlm.nih.gov/21978084 ↗
Cited by:
Pinealon
Khavinson VK. Peptide bioregulators -geroprotective effects on immune and cardiovascular gene expression
pubmed.ncbi.nlm.nih.gov/21267487 ↗
Cited by:
LivagenOvagenProstamaxTestagen
Kim KH et al. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress
pubmed.ncbi.nlm.nih.gov/29983246 ↗
Cited by:
MOTS-C
Kim KR et al. Low-dose growth hormone treatment with diet restriction accelerates body fat loss and improves growth hormone secretory dysfunction in obese adults
pubmed.ncbi.nlm.nih.gov/10352397 ↗
Cited by:
HGH 191AA
Kingsberg SA et al. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
pubmed.ncbi.nlm.nih.gov/31599840 ↗
Cited by:
PT-141 (Bremelanotide)
Kozin SA et al. Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models
pubmed.ncbi.nlm.nih.gov/35080861 ↗
Cited by:
Semax
Kumar P et al. GlyNAC Supplementation Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Aging Hallmarks, Metabolic Defects, and Body Composition
pubmed.ncbi.nlm.nih.gov/34587244 ↗
Cited by:
Glutathione
Lau DCW et al. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
pubmed.ncbi.nlm.nih.gov/34798060 ↗
Cited by:
Cagrilintide
Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
pubmed.ncbi.nlm.nih.gov/25738459 ↗
Cited by:
MOTS-C
Lehert P et al. Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation: a literature review and cost evaluation
pubmed.ncbi.nlm.nih.gov/25480425 ↗
Cited by:
HMG
Luger TA et al. alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells
pubmed.ncbi.nlm.nih.gov/15102092 ↗
Cited by:
KPV
Matheny RW et al. Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration
pubmed.ncbi.nlm.nih.gov/20130113 ↗
Cited by:
MGF
Mazella J et al. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design
pubmed.ncbi.nlm.nih.gov/20405001 ↗
Cited by:
PE-22-28
Mericq V et al. Effects of eight months treatment with graded doses of GHRP-2 in GH-deficient children
pubmed.ncbi.nlm.nih.gov/9661608 ↗
Cited by:
CJC-1295 + GHRP-2 BlendGHRP-2
Merrill GF et al. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle
pubmed.ncbi.nlm.nih.gov/9435525 ↗
Cited by:
AICAR
Muresanu DF et al. Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes
pubmed.ncbi.nlm.nih.gov/33515100 ↗
Cited by:
Cerebrolysin
Neelakantan H et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice
pubmed.ncbi.nlm.nih.gov/29155147 ↗
Cited by:
5-Amino-1MQ
Prakash A et al. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency
pubmed.ncbi.nlm.nih.gov/18031173 ↗
Cited by:
Sermorelin
Raun K et al. Ipamorelin, the first selective growth hormone secretagogue
pubmed.ncbi.nlm.nih.gov/9849822 ↗
Cited by:
AOD-9604 + CJC-1295 + Ipamorelin BlendCJC-1295 DAC (2mg) + Ipamorelin (5mg) StackCJC-1295 No DAC + Ipamorelin BlendIpamorelinTesamorelin + Ipamorelin Blend
Rosenstock J et al. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial
pubmed.ncbi.nlm.nih.gov/37385280 ↗
Cited by:
Retatrutide
Sarafraz-Yazdi E et al. Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes
pubmed.ncbi.nlm.nih.gov/20080680 ↗
Cited by:
PNC-27
Sikiric P et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
pmc.ncbi.nlm.nih.gov/articles/PMC5333585 ↗
Cited by:
BPC-157BPC-157 + TB-500 BlendTB-500 (5mg) + BPC-157 (5mg) StackTri-Heal (TB-500 + BPC-157 + KPV)
Sosne G et al. Biological activities of thymosin beta4 defined by active sites in short peptide sequences
pubmed.ncbi.nlm.nih.gov/20179146 ↗
Cited by:
BPC-157 + TB-500 BlendTB-500TB-500 (5mg) + BPC-157 (5mg) StackTri-Heal (TB-500 + BPC-157 + KPV)
Stavchansky VV et al. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia
pubmed.ncbi.nlm.nih.gov/24661604 ↗
Cited by:
Semax
Teichman SL et al. Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
pubmed.ncbi.nlm.nih.gov/16352683 ↗
Cited by:
CJC-1295 DACCJC-1295 DAC (2mg) + Ipamorelin (5mg) Stack
Van IJzendoorn MH et al. The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans
pubmed.ncbi.nlm.nih.gov/20047458 ↗
Cited by:
Oxytocin
Volkova A et al. Efficacy of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation
pubmed.ncbi.nlm.nih.gov/24913576 ↗
Cited by:
Selank
Wang T et al. Pulsatile Gonadotropin-Releasing Hormone Therapy for Spermatogenic Outcomes in Patients With Pituitary Stalk Interruption Syndrome
pubmed.ncbi.nlm.nih.gov/38029930 ↗
Cited by:
Gonadorelin
Wessells H et al. Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II
pubmed.ncbi.nlm.nih.gov/11035391 ↗
Cited by:
Melanotan II
Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
pubmed.ncbi.nlm.nih.gov/35441470 ↗
Cited by:
Semaglutide
Zhao W et al. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice
pubmed.ncbi.nlm.nih.gov/31747905 ↗
Cited by:
SS-31 (Elamipretide)
No references match your search.